Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 1, 2009, Pages 97.e1-97.e5

  Fang, Yu Ming Victor ^a   Benn, Peter ^a   Campbell, Winston ^a   Bolnick, Jay ^a   Prabulos, Anne Marie ^a   Egan, James F X ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

amniocentesis; chorionic villous sampling; Down syndrome; first trimester screening; quad screen

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOWN SYNDROME; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MOTHER FETUS RELATIONSHIP; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SECOND TRIMESTER PREGNANCY; STUDENT T TEST; UNITED STATES;

EID: 67649378438     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.02.029     Document Type: Article

References (13)

1. Wald N.J., Kennard A., Hackshaw A., and McGuire A. Antenatal screening for Down's syndrome. [published erratum appears in J Med Screen 1998;5:110.]. J Med Screen 4 (1997) 181-246
2. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down syndrome. N Engl J Med 353 (2005) 2001-2011
3. Egan J.F., Kaminsky L.M., DeRoche M.E., Barsoom M.J., Borgida A.F., and Benn P.A. Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists. Am J Obstet Gynecol 187 (2002) 1230-1234
4. Wapner R.J., Thom E.A., Simpson J.L., et al. First-trimester screening for trisomies 21 and 18: first trimester maternal serum biochemistry and fetal nuchal translucency screening (BUN) study group. N Engl J Med 349 (2003) 1405-1413
5. Wald N.J., Rodeck C., Hackshaw A.K., Walters J., Chitty L., and Mackinson A.M. First and second trimester antenatal screening for Down syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10 (2003) 56-104
6. Fang Y.M.V., Benn P., and Egan J.F.X. Use of the genetic sonogram in the United States in 2001 and 2007. J Ultrasound Med 27 (2008) 1543-1548
7. Benn P.A., and Egan J.F.X. Expected performance of second trimester maternal serum testing followed by a "genetic sonogram" in screening of fetal Down syndrome. Prenat Diagn 27 (2008) 230-235
8. Ball R.H., Caughey A.B., Malone F.D., et al. First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol 110 (2007) 10-17
9. ACOG Committee on Practice Bulletins. ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 109 (2007) 217-227
10. Benn P., Egan J.F., Fang M., and Smith-Bindman R. Changes in the utilization of prenatal diagnosis. Obstet Gynecol 103 (2004) 1255-1260
11. Jenkins T.M., Sciscione A.C., Wapner R.J., and Sarto G.E. Training in chorionic villous sampling: limited experience for US fellows. Am J Obstet Gynecol 191 (2004) 1288-1290
12. Caughey A.B., Hopkins L.M., and Norton M.E. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 108 (2006) 612-616
13. Eddleman K.A., Malone F.D., Sullivan L., et al. Pregnancy loss rates after mid trimester amniocentesis. Obstet Gynecol 108 (2006) 1067-1072